Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. (0HIY.L) Stock Overview
Explore Atara Biotherapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
81.6M
P/E Ratio
-8.19
EPS (TTM)
$-3.65
ROE
0.18%
0HIY.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Atara Biotherapeutics, Inc. (0HIY.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 65.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.77.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.19 and a market capitalization of 81.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.